“…Although the biological functions of adiponectin vary substantially, adiponectin is known to have beneficial metabolic functions, such as insulin-sensitizing, anti-atherogenic, anti-inflammatory properties, and so on [ 1 , 2 , 3 , 4 , 5 ]. Therefore, various studies were conducted on the relationship between serum adiponectin concentrations and various diseases, such as type 2 diabetes (T2D), cardiovascular disease (CVD), cancer, polycystic ovary syndrome (PCOS), and cognitive dysfunction, but with conflicting results [ 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ]. We hypothesized that a factor influencing this conflicting relationship might be differences in kidney function.…”